63 employees
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
2013
$962K
from 2 investors over 2 rounds
Clene Nanomedicine raised $339K on October 14, 2019
Investors: National MS Society
Clene Nanomedicine raised $962K on September 16, 2019
Investors: FIGHTMND